ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $463,000 | -10.6% | 10,500 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $518,000 | +15.1% | 10,500 | -1.9% | 0.01% | +20.0% |
| Q4 2020 | $450,000 | -8.2% | 10,700 | 0.0% | 0.01% | -28.6% |
| Q3 2020 | $490,000 | -79.0% | 10,700 | -76.9% | 0.01% | -78.1% |
| Q2 2020 | $2,328,000 | +2.5% | 46,360 | +5.0% | 0.03% | -11.1% |
| Q1 2020 | $2,272,000 | -17.0% | 44,160 | 0.0% | 0.04% | +33.3% |
| Q4 2019 | $2,738,000 | +1.6% | 44,160 | -1.5% | 0.03% | -6.9% |
| Q3 2019 | $2,694,000 | -28.8% | 44,840 | 0.0% | 0.03% | -29.3% |
| Q2 2019 | $3,784,000 | -13.2% | 44,840 | -1.7% | 0.04% | -14.6% |
| Q1 2019 | $4,358,000 | -13.5% | 45,621 | -35.8% | 0.05% | -26.2% |
| Q4 2018 | $5,038,000 | -17.1% | 71,114 | 0.0% | 0.06% | +12.1% |
| Q3 2018 | $6,077,000 | -26.2% | 71,114 | +0.1% | 0.06% | -28.4% |
| Q2 2018 | $8,231,000 | +42.7% | 71,014 | -0.4% | 0.08% | +37.3% |
| Q1 2018 | $5,770,000 | +29.9% | 71,314 | -5.8% | 0.06% | +40.5% |
| Q4 2017 | $4,442,000 | +24.2% | 75,704 | -0.9% | 0.04% | +44.8% |
| Q3 2017 | $3,576,000 | +27.8% | 76,409 | -1.8% | 0.03% | +20.8% |
| Q2 2017 | $2,799,000 | +16.0% | 77,792 | -0.7% | 0.02% | +14.3% |
| Q1 2017 | $2,413,000 | -8.0% | 78,341 | 0.0% | 0.02% | 0.0% |
| Q4 2016 | $2,624,000 | +8.3% | 78,341 | -13.9% | 0.02% | +10.5% |
| Q3 2016 | $2,422,000 | +20.7% | 91,016 | 0.0% | 0.02% | +11.8% |
| Q2 2016 | $2,007,000 | -28.8% | 91,016 | -5.1% | 0.02% | -37.0% |
| Q1 2016 | $2,817,000 | -6.3% | 95,916 | +5.4% | 0.03% | -6.9% |
| Q4 2015 | $3,005,000 | +7.3% | 91,016 | +17.4% | 0.03% | 0.0% |
| Q3 2015 | $2,801,000 | -19.7% | 77,513 | 0.0% | 0.03% | -32.6% |
| Q2 2015 | $3,487,000 | +46.9% | 77,513 | 0.0% | 0.04% | +59.3% |
| Q1 2015 | $2,373,000 | -39.8% | 77,513 | 0.0% | 0.03% | -40.0% |
| Q4 2014 | $3,942,000 | – | 77,513 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |